Our aims were to 1) present these data for the STANDARD G6PD Test, 2) explore how a common set of thresholds to classify G6PD deficient or intermediate individuals with POC testing can be applied across populations, and 3) consider the implications of the test performance on 8-aminoquinoline malaria treatment regimens. This evidence concerns the gene G6PD and malaria.